HIF1A and neoplasm: Exosomal miR-23a may directly target PHD1 and PHD2 in the endothelial cells, within the tumor microenvironment, which further induces the accumulation of hypoxia-inducible factor (HIF)-1α and promotes tumor angiogenesis.